Further studies will be necessary to explore the relationship between increased ISG12 protein levels in breast cancer patients with tumor progression, metastatic disease and to explore the potential of ISG12 expression levels in the development of new diagnostic and therapeutic strategies. The gene discussed is IFI27; the disease is breast cancer.